This study compared differences in functional connectivity in nociceptive processing brain regions between irritable/nonirritable phenotypes in painful diabetic neuropathy.
The researchers sought to assess the cost-effectiveness of OUD treatments and association of treatments with outcomes in the United States.
Pooled data analyses on efficacy, safety, and 1-year follow-up on the use of tirbanibulin for the treatment of actinic keratosis lesions was presented at the AAD VMX 2021.
Researchers analyzed the predictors, trends, and outcomes of opioid use disorder in patients with chronic pancreatitis.
More studies about antidepressants as chronic pain therapy are needed because current drug treatments are ineffective and pose a high risk for serious harm.
The authors propose evaluating which aspects of previous policy and practices for OUD should resume and which aspects of current policy and practice exemptions should continue.
Examining whether an early career episode of burnout has long-term consequences on cognitive functions, symptoms of depression, and insomnia for nurses a decade after graduation.
Opioid products approved by the FDA between 1997 and 2018 relied on short- or intermediate-term studies that did not adequately analyze safety outcomes.
Pregnancy and insurance status were significant barriers to obtaining appointments for opioid use disorder treatment.
The increased risk for frequent nonmedical cannabis use among individuals with pain was elevated when comparing between surveys in the 2 time periods.
